Mucinous cystadenoma of the ovary - Revision history

Michael at 16:36, 1 March 2018

2018-03-01T16:36:39Z

← Older revision		Revision as of 16:36, 1 March 2018
Line 11:		Line 11:
	\| IHC =		\| IHC =
	\| EM =		\| EM =
	\| Molecular =		\| Molecular = +/-[[KRAS mutation]]
	\| IF =		\| IF =
	\| Gross = multiloculated cystic lesion, thin cyst walls/no solid areas		\| Gross = multiloculated cystic lesion, thin cyst walls/no solid areas

2018-03-01T16:36:17Z

2018-03-01T16:35:49Z

2018-03-01T16:31:39Z

Molecular

← Older revision		Revision as of 16:31, 1 March 2018
Line 77:		Line 77:

	==Molecular==		==Molecular==
	*KRAS ~~mutations~~ common ~ 56% of mucinous cystadenomas in one series.<ref name=pmid9118042>{{Cite journal \| last1 = Cuatrecasas \| first1 = M. \| last2 = Villanueva \| first2 = A. \| last3 = Matias-Guiu \| first3 = X. \| last4 = Prat \| first4 = J. \| title = K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. \| journal = Cancer \| volume = 79 \| issue = 8 \| pages = 1581-6 \| month = Apr \| year = 1997 \| doi = \| PMID = 9118042 }}</ref>		*[[KRAS mutation]]s common ~ 56% of mucinous cystadenomas in one series.<ref name=pmid9118042>{{Cite journal \| last1 = Cuatrecasas \| first1 = M. \| last2 = Villanueva \| first2 = A. \| last3 = Matias-Guiu \| first3 = X. \| last4 = Prat \| first4 = J. \| title = K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. \| journal = Cancer \| volume = 79 \| issue = 8 \| pages = 1581-6 \| month = Apr \| year = 1997 \| doi = \| PMID = 9118042 }}</ref>

	==Sign out==		==Sign out==

2018-03-01T16:31:29Z

Molecular

← Older revision		Revision as of 16:31, 1 March 2018
Line 77:		Line 77:

	==Molecular==		==Molecular==
	*KRAS mutations common ~ 56% in one series.<ref name=pmid9118042>{{Cite journal \| last1 = Cuatrecasas \| first1 = M. \| last2 = Villanueva \| first2 = A. \| last3 = Matias-Guiu \| first3 = X. \| last4 = Prat \| first4 = J. \| title = K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. \| journal = Cancer \| volume = 79 \| issue = 8 \| pages = 1581-6 \| month = Apr \| year = 1997 \| doi = \| PMID = 9118042 }}</ref>		*KRAS mutations common ~ 56% of mucinous cystadenomas in one series.<ref name=pmid9118042>{{Cite journal \| last1 = Cuatrecasas \| first1 = M. \| last2 = Villanueva \| first2 = A. \| last3 = Matias-Guiu \| first3 = X. \| last4 = Prat \| first4 = J. \| title = K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. \| journal = Cancer \| volume = 79 \| issue = 8 \| pages = 1581-6 \| month = Apr \| year = 1997 \| doi = \| PMID = 9118042 }}</ref>

	==Sign out==		==Sign out==

2018-03-01T16:29:13Z

← Older revision		Revision as of 16:29, 1 March 2018
Line 75:		Line 75:
	Image: Ovarian mucinous cystadenoma - a3- very high mag.jpg \| OMC - very high mag.		Image: Ovarian mucinous cystadenoma - a3- very high mag.jpg \| OMC - very high mag.
	</gallery>		</gallery>

			==Molecular==
			*KRAS mutations common ~ 56% in one series.<ref name=pmid9118042>{{Cite journal \| last1 = Cuatrecasas \| first1 = M. \| last2 = Villanueva \| first2 = A. \| last3 = Matias-Guiu \| first3 = X. \| last4 = Prat \| first4 = J. \| title = K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. \| journal = Cancer \| volume = 79 \| issue = 8 \| pages = 1581-6 \| month = Apr \| year = 1997 \| doi = \| PMID = 9118042 }}</ref>

	==Sign out==		==Sign out==

2018-02-15T17:06:52Z

Mucinous cystadenoma with focal proliferation

← Older revision		Revision as of 17:06, 15 February 2018
Line 88:		Line 88:

	Comment:		Comment:
	The proliferative component is less than 10%.		The proliferative component is less than 10% of the lesion.
	</pre>		</pre>

2018-02-15T17:06:30Z

Mucinous cystadenoma with focal proliferation

← Older revision		Revision as of 17:06, 15 February 2018
Line 88:		Line 88:

	Comment:		Comment:
	The proliferative component is ~~judged to be~~ less than 10%.		The proliferative component is less than 10%.
	</pre>		</pre>

2018-02-15T17:05:59Z

Focal proliferation present

← Older revision		Revision as of 17:05, 15 February 2018
Line 82:		Line 82:
	</pre>		</pre>

	==~~Focal~~ proliferation ~~present~~==		===Mucinous cystadenoma with focal proliferation===
	<pre>		<pre>
	Left Ovarian Cyst, Excision:		Left Ovarian Cyst, Excision:
	- Mucinous cystadenoma with focal proliferation.		- Mucinous cystadenoma with focal proliferation, see comment.

			Comment:
			The proliferative component is judged to be less than 10%.
	</pre>		</pre>

2018-02-15T17:02:03Z

Sign out

← Older revision		Revision as of 17:02, 15 February 2018
Line 80:		Line 80:
	Left Ovarian Cyst, Excision:		Left Ovarian Cyst, Excision:
	- Mucinous cystadenoma.		- Mucinous cystadenoma.
			</pre>

			==Focal proliferation present==
			<pre>
			Left Ovarian Cyst, Excision:
			- Mucinous cystadenoma with focal proliferation.
	</pre>		</pre>

← Older revision		Revision as of 16:36, 1 March 2018
Line 96:		Line 96:
	==See also==		==See also==
	*[[Ovarian tumours]].		*[[Ovarian tumours]].
			*[[Mucinous ovarian tumours]].
	*[[Mucinous cystadenoma]].		*[[Mucinous cystadenoma]].
	*[[Mucinous cystadenoma of the appendix]].		*[[Mucinous cystadenoma of the appendix]].
	*[[Mucinous ovarian tumours]].

	==References==		==References==

← Older revision		Revision as of 16:35, 1 March 2018
Line 98:		Line 98:
	*[[Mucinous cystadenoma]].		*[[Mucinous cystadenoma]].
	*[[Mucinous cystadenoma of the appendix]].		*[[Mucinous cystadenoma of the appendix]].
			*[[Mucinous ovarian tumours]].

	==References==		==References==